Skip to main content
. 2016 Aug;6(4):322–339. doi: 10.21037/cdt.2015.12.08

Table 1. Non-invasive study.

Modality/marker First author Outcome description Composite No. of total events All cause death Cardiac death Cardiac arrest MI (STEMI/NSTEMI) UAP SAP Coronary revascularization Duration of follow-up
CT
   CAC score Yeboah Coronary heart disease 104 × Δ 7.6 yr*
Detrano Coronary heart disease 162 × × 3.9 yr*
Erbel Non-fatal MI + cardiac death 93 × × × × × 5 yr*
Russo Hard cardiac events 44 × × × × 34.8 mon**
Elias-Smale Coronary heart disease 135 × × × × × 9.2 yr*
   CTCA (Luminal narrowing) Min 2007 All-cause death × 39 × × × × × × 15.3 mon**
Hadamitzky 2011 Cardiac events 47 × × × 28 mon*
Hadamitzky 2013 All-cause death × 347 × × × × × × 2.3 yr*
Plank MACE 6 × × × × × 2.65 yr**
Hou MACE + hard MACE 363 × × × × 1,081 day*
Andreini MACE + hard MACE 259 × × × × 52 mon**
Min 2014 MACE 33 × × × × 2.4 yr**
Schlett MACE 35 × × × × 2 yr*
   Total plaque burden Versteylen ACS × 25 × × × ○ (ACS) × × 26 mon**
   PR, LAP and Napkin ring sign Otsuka Cardiac death or ACS event 24 × × × × 3 yr*
CMR
   MR coronary angiographic stenosis Yoon Combined cardiac endpoints 13 × × × × 25 mon*
   Coronary high-intensity plaque Noguchi Combined endpoints 55 × × × 55 mon

Note: “○” means used as a component of composite endpoints and “×” does not used. “Ä” means that it has been reported but included in coronary revascularization. *, median; **, average; MI, myocardial infarction; UAP, unstable angina; SAP, stable angina; CT, computed tomography; CMR, cardiac magnetic resonance imaging; CAC, coronary artery calcium; CTCA, computed tomography coronary angiography; PR, positive remodeling; LAP, low attenuation plaque; MACE, major adverse cardiovascular event; ACS, acute coronary syndrome.